Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-69
SponsorADVANCED MARKER DISCOVERY S.L.

About this trial

The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:

* Values of experience of participants into screening programme. * Values of preferences of participants for screening methods.

Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Participants ages from 50 to 69 years (both included) at the time of informed consent signed.

Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center.

Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.

Disqualifiers

Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form.

Participants with a previous colonoscopy in consequence of a FOBT positive result.

Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.

Trial design

Design model

Single group

Treatments tested in this trial

  • Survey using a questionnaire.

    Other intervention

    Preference questionnaire for colorectal cancer screening methods

  • Survey using a questionnaire.

    Other intervention

    Experience questionnaire into colorectal cancer screening programme

Treatment groups

1,000 Participants
are divided into 1 treatment group
Group A: FIT/FOBT populationOther 1 intervention

Trial outcomes

Primary outcomes

1

Value of questionnaires into screening programme

The percentage of number of answers from each experience and preference questions

Time frame
12 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

ADVANCED MARKER DISCOVERY S.L.

Lead sponsor

SERMAS

Collaborator

ULS de Santa Maria

Collaborator